Panel Discussion: Optimizing Patient Treatment Procedure for Best Outcomes

Moderator: Greg Deener, Chief Executive Officer, iCell Gene Therapeutics

Time: 2:00 pm
day: Day Two Track B, PM

Details:

• Discussing regiments for patients such as ideal dosing, timing of certain procedures, and sample collection methods

• Evaluating the need for conditioning regiments such as lymphodepletion

• How long do patients need to be hospitalized?

Speakers: